Exemplifying the Screening Power of Mass Spectrometry Imaging over Label-Based Technologies for Simultaneous Monitoring of Drug and Metabolite Distributions in Tissue Sections. (2016)
Attributed to:
Structuring the Future - Underpinning world-leading science in EaStCHEM through cutting edge characterisation
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/1087057115623740
PubMed Identifier: 26701101
Publication URI: http://europepmc.org/abstract/MED/26701101
Type: Journal Article/Review
Volume: 21
Parent Publication: Journal of biomolecular screening
Issue: 2
ISSN: 1087-0571